Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02350114 · ClinicalTrials.gov registry record · NA
An Observational Study of the Functional Capacity of Heart Failure
A NA study of Acute Heart Failure, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
- 6
- Study locations
NCT02350114 is a NA study of Acute Heart Failure that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 51 participants, below the 1,446-participant average among 8 other Acute Heart Failure trials with a reported enrollment target (96% lower). The trial reports 6 study locations across 5 states.
The verdict
NCT02350114, a NA study of Acute Heart Failure, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
- 6
- Study locations
Study Summary
This is an observational study of the functional capacity of patients with Heart failure with Reduced Ejection Fraction (HFrEF) who are admitted to the hospital for routine medical treatment.
Conditions Studied
Interventions
- PROCEDURE 6 Minute Walk Test
Study Locations (6)
Michigan
- Cardioxyl Study Site - Detroit
- Cardioxyl Study Site - Detroit
Indiana
- Cardioxyl Study Site - Indianapolis
North Carolina
- Cardioxyl Study Site - Winston-Salem
Ohio
- Cardioxyl Study Site - Cincinnati
Tennessee
- Cardioxyl Study Site - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2014-11 |
| Est. Completion | 2015-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02350114
The ClinicalTrials.gov registry entry for NCT02350114 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,446-participant average among 8 other Acute Heart Failure trials with a reported enrollment target (96% lower). The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which 6 Minute Walk Test is the first listed.
NCT02350114 reports 6 study locations spanning 5 distinct geographic areas - top geographies include Michigan, Indiana, North Carolina.
Frequently Asked Questions
What is clinical trial NCT02350114 about?
NCT02350114 is a clinical study titled "An Observational Study of the Functional Capacity of Heart Failure". This is an observational study of the functional capacity of patients with Heart failure with Reduced Ejection Fraction (HFrEF) who are admitted to the hospital for routine medical treatment.
What is the current status of trial NCT02350114?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2014-11. Estimated completion is 2015-07.
What conditions does trial NCT02350114 study?
This clinical trial studies the following conditions: Acute Heart Failure.
What interventions are being tested in trial NCT02350114?
The interventions under investigation include: 6 Minute Walk Test (PROCEDURE).
Who is sponsoring clinical trial NCT02350114?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02350114 being conducted?
This trial has 6 study locations across Indiana, Michigan, North Carolina, Ohio, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Impact of Validated Diagnostic Prediction Model of Acute Heart Failure in the Emergency Department
COMPLETED · NA
-
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
RECRUITING · Phase 3
-
Improving Diagnostic Accuracy for Acute Heart Failure
ACTIVE NOT RECRUITING
-
Randomized Controlled Trial of urinE chemiStry Guided aCute heArt faiLure treATmEnt (ESCALATE)
ACTIVE NOT RECRUITING · Phase 2
-
Subcutaneous Furosemide in Acute Decompensated Heart Failure Pilot
COMPLETED · Phase 1
-
Tezosentan in Acute Heart Failure
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.